Alecensa (Alectinib) 150mg Capsules | Roche India for ALK+ NSCLC | GLT

Generic Information: Alecensa (Alectinib) — India Version

This is the Indian presentation of Roche's Alecensa — alectinib capsules 150 mg, carrying the Hindi transliteration अलेकसेंसा alongside the international branding and marketed in India by Roche Products India Pvt Ltd, the subsidiary of F. Hoffmann-La Roche. India matters in the alectinib story for a simple reason: it is one of the few markets where the originator company itself sells the medicine at Indian-market terms, backed by a structured patient-assistance program — a genuinely different access route from the grey market.

What Is Alecensa (Alectinib) Used For?

Indian oncologists use Alecensa for ALK-positive locally advanced or metastatic non-small cell lung cancer — as preferred first-line systemic therapy and after crizotinib failure — with the molecule's intracranial activity doing much of the persuasive work, since ALK-positive disease seeds the brain early and often. The adjuvant indication after resection of higher-risk ALK-positive tumors is likewise referenced in Indian practice as it is globally. As everywhere, an approved molecular test must document the ALK rearrangement before the first capsule.

How Does Alecensa (Alectinib) Work?

Alectinib is a selective inhibitor of the ALK fusion tyrosine kinase — and of RET kinase as a laboratory target — engineered to keep activity against multiple crizotinib-resistance mutations and to cross from the bloodstream into brain tissue. It reaches effective concentrations in the central nervous system because it is not expelled by the P-gp/BCRP efflux machinery at the blood-brain barrier; its M4 metabolite contributes comparable ALK blockade. Food multiplies its absorption, which is why dosing is anchored to meals.

Indications of Alecensa (India)

The Indian label mirrors the international core: ALK-positive metastatic NSCLC, first-line and post-crizotinib, with adjuvant use after resection of tumors of 4 cm or more or node-positive disease referenced under the updated global label that Indian practice follows. ALK-negative lung cancer gains nothing from this drug — testing first is not a formality, it is the whole gate.

Dosage and Administration

Standard adult dosing is 600 mg (four 150 mg capsules) twice daily with food — with breakfast and with dinner roughly twelve hours apart. In severe hepatic impairment (Child-Pugh C) therapy starts at 450 mg twice daily. Dose reductions proceed by 150 mg steps per administration; permanent discontinuation follows intolerance of 300 mg twice daily. Capsules are swallowed intact with water; missed doses are made up unless the next one is due within six hours, and vomiting is not re-dosed.

Side Effects of Alecensa (India)

Indian clinicians manage the same spectrum documented worldwide: constipation, peripheral and periorbital edema, muscle aches, fatigue, anemia, skin reactions and pronounced photosensitivity lead the list, with hepatotoxicity, ILD/pneumonitis, bradycardia, CPK elevation and hemolytic anemia as the serious-monitoring items. Standard Indian practice runs liver panels and CPK every two weeks through the initial period, checks pulse and blood pressure at reviews, and treats new breathlessness or persistent cough as an urgent imaging question. Contraception during and after therapy is discussed with every patient of childbearing potential.

Storage Instructions

Store below 30°C in the original carton, protected from light and moisture — practical in Indian conditions if the pack is kept out of direct sun and away from kitchens. Opened blister strips are used within the labeled window. Keep out of children's reach.

Why Choose Alecensa (India) from GLT?

Three reasons buyers ask for the India presentation: it is the originator molecule at Indian-market packaging and pricing logic, it ships in Roche cartons that pharmacists across Asia and Africa recognize, and it typically lands dramatically cheaper than US-channel supply — GLT quotes it routinely at a large discount to US list, with the exact figure on request. GLT verifies batch and expiry before dispatch, supports both individual patients and institutional tenders, and answers every enquiry personally on WhatsApp +86 15234153837 or [email protected]. If the Indian channel is constrained, we will say so and offer the equivalent Roche packs from other markets or certified generics instead.

How to Order Alecensa (Alectinib)

Enquire with product name and quantity, receive a written quotation with courier and payment options, confirm, and GLT dispatches with complete export paperwork; CoA and batch photos are available before payment for institutional buyers. The fastest routes are WhatsApp +86 15234153837 and [email protected] — both are checked daily.

FAQ

Is the Indian Alecensa genuine Roche? Yes — it is imported/marketed by Roche Products India Pvt Ltd; GLT supplies sealed stock with batch documentation.

How many capsules in the India box? The standard retail box holds 56 capsules of 150 mg (one week at the eight-capsules-a-day schedule); the larger multipack combines four such boxes into 224.

How does the India price compare globally? Indian-market terms sit far below US list pricing for the same month of therapy; ask us for the current quotation.

Can I take it without an ALK test? No — benefit is confined to ALK-rearranged disease, and every serious supplier will ask for the test report.

Does GLT also stock alectinib generics? Yes — Alecnib (Bangladesh), Alynni, LuciAle and Ailedx (Laos) are on our shelf; we will compare packs and costs for you.

What about customs paperwork? Standard export documents ship with every order; institutions receive the additional set they typically need.